TOP 30 Radiotherapy oncology in Rochester, New York

6 results found

UR Medicine Radiation Oncology – Elena Nedea, MD is a leading medical institution located at 601 Elmwood Avenue in Rochester, New York. Dr. Elena Nedea specializes in radiation oncology, offering advanced treatment options for patients with cancer. With a focus on personalized care and cutting-edge technology, Dr. Nedea and her team provide compassionate and effective care to help patients achieve the best possible outcomes. Whether you are in need of radiation therapy or seeking a second opinion, UR Medicine Radiation Oncology – Elena Nedea, MD is committed to providing top-quality healthcare in a welcoming and supportive environment.

Michael A. Cummings, MD is a doctor specializing in Radiation Oncology located at 601 Elmwood Avenue, Rochester, New York, United States. Dr. Cummings is an Associate Professor in the Department of Radiation Oncology at the University of Rochester Medical Center. He completed his Residency in Radiation Oncology at the University of Rochester Medical Center and his Internship in Internal Medicine at SUNY Upstate Medical University. Dr. Cummings received his MD from SUNY Upstate College of Health Professions. Dr. Cummings is involved in various research studies and clinical trials aimed at improving cancer treatment, including using the Decipher risk score to personalize treatment plans based on individual cancer aggressiveness and investigating the use of acupuncture-like electrical therapy for dry mouth in head and neck cancer patients post-radiation treatment.

Haoming (Carl) Qiu, MD is an institution located at 601 Elmwood Avenue in Rochester, New York, United States. Dr. Qiu is an Associate Professor in the Department of Radiation Oncology at the University of Rochester Medical Center. He specializes in treating patients with colorectal cancer that has spread to multiple body sites, as well as early-stage anal cancer. Dr. Qiu is involved in several research studies exploring the use of radiation therapy in modulating the immune microenvironment of pancreatic ductal adenocarcinoma and other types of cancer. He has also co-authored numerous publications on topics such as stereotactic body radiation therapy and the effects of dexamethasone on tumor response to radiotherapy. Patients at URMC have the opportunity to provide feedback on their care experience through surveys conducted by Press Ganey, allowing for transparency and informed decision-making. Visit the website to learn more about Dr. Qiu and the services offered at this institution.

Michael Milano, MD, PhD is a renowned doctor specializing in health and located at 601 Elmwood Avenue, Rochester, New York, United States. Dr. Milano completed his Residency at the University of Chicago, Pritzker School of Medicine from 2001 to 2005, and his Internship in Internal Medicine at the University of Rochester Medical Center from 2000 to 2001. He has received numerous awards and recognitions for his outstanding contributions to the field, including being named an Outstanding Reviewer in 2018 by the International Journal of Radiation Oncology Biology Physics. Dr. Milano is currently involved in a phase III trial comparing the effects of stereotactic radiosurgery for patients with brain metastases and small cell lung cancer. His research and publications have been widely recognized in prestigious journals such as Radiotherapy and Oncology and the International Journal of Radiation Oncology Biology Physics. With his expertise and dedication to advancing healthcare, Dr. Milano is a trusted and respected figure in the medical community.

Kevin Bylund, MD is a doctor specializing in Radiation Oncology located at 1000 South Avenue, Rochester, New York, United States. Dr. Bylund is an Associate Professor in the Department of Radiation Oncology at the University of Rochester School of Medicine and Dentistry. He has received multiple awards for his research in the field of oncology. Dr. Bylund's expertise includes treating high risk prostate cancer and low gene risk score patients with less intense hormone therapy and radiation therapy. He has also conducted research on the use of angiotensin converting enzyme inhibitors to reduce late bladder toxicity following radiotherapy for prostate cancer.

Kevin Bylund, MD is an institution located at 601 Elmwood Avenue in Rochester, New York, United States. Dr. Bylund is an Associate Professor in the Department of Radiation Oncology at the University of Rochester Medical Center. He completed his Residency in Radiation Oncology at the University of Rochester Medical Center and his Internship in Internal Medicine at St. Louis University School of Medicine/Medical Center. Dr. Bylund has received multiple awards for his research in the field of oncology. The institution offers a variety of services including treatment for high-risk prostate cancer, research on reducing bladder toxicity following radiotherapy, and building high-dose-rate prostate brachytherapy programs. Dr. Bylund has also conducted research on the utility of topical agents for radiation dermatitis and pain, as well as the prognostic significance of sites of visceral metastatic disease in prostate cancer.